Loading data
PMCBNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Research and development expense | 391.3 k USD | 438.42 k USD | 407.43 k USD | 468.54 k USD | 690.94 k USD |
| Operating profit | -6.85 m USD | -4.38 m USD | -8.52 m USD | -6.46 m USD | -4.39 m USD |
| Interest expense | — | — | — | 0 USD | 509 USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -19.42 m USD | 30.66 m USD | 300 k USD | -4.3 m USD | -4.24 m USD |
| Net income attributable to common shareholders | -23.21 m USD | 23.36 m USD | -17.24 m USD | -4.32 m USD | — |
| Basic earnings per share | -2.77 USD/share | 3.19 USD/share | -1.8 USD/share | -0.22 USD/share | -0.27 USD/share |
| Diluted earnings per share | -2.77 USD/share | 3.19 USD/share | -1.8 USD/share | -0.22 USD/share | -0.27 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.